5 Articles
5 Articles
Major Recalls: Glenmark and FDC Tackle USFDA Warnings
Major Recalls: Glenmark and FDC Tackle USFDA Warnings Drug manufacturers Glenmark Pharmaceuticals and FDC Ltd are pulling back products from the United States market due to manufacturing complications, according to the US Food and Drug Administration (USFDA).The US health regulator disclosed in its latest Enforcement Report that Glenmark Pharmaceuticals' US subsidiary is withdrawing certain batches of a generic hypertension drug.Headquartered in…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage